February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small relative decrease in cardiovascular mortality among middle-aged adults. The study was published this week in the Journal of the American Medical Association (JAMA).


February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2021. This is based on the website’s record 726,770 pageviews for the month. 

1. iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.

January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the fourth quarter of 2020, when compared to the four-quarter average, according to the healthcare market research firm GlobalData.

A total of 220 deals worth $16.93 billion were announced for the region during Q4 2020, against the last four-quarter average of 266 deals.

Of all the deal types, venture financing saw most activity in Q4 2020 with 127, representing a 57.7% share for the region.

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. 

But while this pandemic will end at some point, it is quite unlikely that we will completely eradicate the novel coronavirus that causes COVID-19 (SARS-CoV-2) — the way we did, for instance, with the virus that causes smallpox.

January 27, 2021 — Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for managing AAA patients. Based on 3-D ultrasound, Philips AAA Model delivers clinicians accurate diagnostic information without exposing patients to high doses of radiation and nephrotoxic contrast agents.

January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute for research to improve the understanding of atherosclerosis and deliver a new treatment for heart disease. 

January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction.

January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company a Breakthrough Device Designation for the periprocedural use of its Pedra Xauron Perfusion System in the treatment of critical limb threatening ischemia (CLTI).

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-Eluting Stent (DES) system. The company said it is the first platform that is purpose-built for large, proximal vessels.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now